AR063570A1 - Efectos biologicos mejorados para composiciones que comprenden acido rosmarinico - Google Patents
Efectos biologicos mejorados para composiciones que comprenden acido rosmarinicoInfo
- Publication number
- AR063570A1 AR063570A1 ARP070104924A ARP070104924A AR063570A1 AR 063570 A1 AR063570 A1 AR 063570A1 AR P070104924 A ARP070104924 A AR P070104924A AR P070104924 A ARP070104924 A AR P070104924A AR 063570 A1 AR063570 A1 AR 063570A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- biological effects
- rosmarinic acid
- improved biological
- include rosmarinic
- Prior art date
Links
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 title abstract 2
- 230000004071 biological effect Effects 0.000 title abstract 2
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 title abstract 2
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 title abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 230000003301 hydrolyzing effect Effects 0.000 abstract 2
- 244000005700 microbiome Species 0.000 abstract 1
- 235000020748 rosemary extract Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
- A23L31/10—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Enzymes And Modification Thereof (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Composiciones que comprenden ácido rosmarínico y/o sus derivados y el uso de una enzima hidrolítica o de microorganismo que contiene o produce enzimas hidrolíticas en estas composiciones. También tiene relación con métodos para mejorar los efectos biológicos de dichos extractos de romero.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06023060A EP1917960A1 (en) | 2006-11-06 | 2006-11-06 | Improved biological effects of rosmarinic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR063570A1 true AR063570A1 (es) | 2009-02-04 |
Family
ID=37814047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070104924A AR063570A1 (es) | 2006-11-06 | 2007-11-05 | Efectos biologicos mejorados para composiciones que comprenden acido rosmarinico |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8932579B2 (es) |
| EP (2) | EP1917960A1 (es) |
| CN (1) | CN101563078B (es) |
| AR (1) | AR063570A1 (es) |
| AT (1) | ATE461699T1 (es) |
| AU (1) | AU2007316954B2 (es) |
| BR (1) | BRPI0718533B8 (es) |
| CA (1) | CA2668472C (es) |
| CL (1) | CL2007003203A1 (es) |
| DE (1) | DE602007005506D1 (es) |
| ES (1) | ES2344127T3 (es) |
| MX (1) | MX2009004739A (es) |
| TW (1) | TWI494101B (es) |
| WO (1) | WO2008055651A1 (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2210504A1 (en) * | 2009-01-27 | 2010-07-28 | Nestec S.A. | Composition comprising chicoric acid and/or derivatives thereof |
| ES3005933T3 (en) | 2011-06-20 | 2025-03-17 | Heinz Co Brands H J Llc | Probiotic compositions and methods |
| WO2013190068A1 (en) * | 2012-06-22 | 2013-12-27 | Nestec S.A. | Probiotic and polyphenol against neurodegeneration |
| CN104619317A (zh) * | 2012-09-21 | 2015-05-13 | 雀巢产品技术援助有限公司 | 用于预防或减少tewl及相关病症和疾病的包含植物酚类的组合物 |
| BR112015005921A2 (pt) * | 2012-09-21 | 2017-07-04 | Nestec Sa | fenóis da planta e seu uso no tratamento ou prevenção de esofagite eosinofílica |
| CN103083207A (zh) * | 2013-01-18 | 2013-05-08 | 吉林农业大学 | 皮肤营养护理液 |
| WO2015095545A1 (en) * | 2013-12-20 | 2015-06-25 | Abbott Laboratories | Nutritional composition containing oxidizable oil and rosmarinic acid |
| RU2552790C1 (ru) * | 2014-01-13 | 2015-06-10 | Федеральное государственное бюджетное учреждение науки Институт биологии Коми научного центра Уральского отделения Российской академии наук | Противоожоговая композиция |
| US9307860B2 (en) | 2014-02-14 | 2016-04-12 | Remington Designs, Llc | Processor control of solute extraction system |
| RU2017101522A (ru) * | 2014-06-19 | 2018-07-19 | Кемин Индастриз, Инк. | Ингредиенты для отсроченного окисления молочного жира |
| MX2017004582A (es) * | 2014-10-08 | 2017-10-12 | Abbott Lab | Composiciones nutricionales que comprenden un componente oxidable y un extracto de plantas solubles en agua. |
| WO2016090436A1 (en) * | 2014-12-11 | 2016-06-16 | Saluda Medical Pty Ltd | Method and device for feedback control of neural stimulation |
| CN105475990B (zh) * | 2015-11-30 | 2019-10-08 | 杭州鑫伟低碳技术研发有限公司 | 一种灵芝孢子粉或灵芝多糖悬浮凝胶的制造方法 |
| CN106360727B (zh) * | 2016-11-22 | 2023-06-27 | 江南大学 | 一种植物的综合利用方法 |
| CN106578403B (zh) * | 2016-12-07 | 2020-12-01 | 江南大学 | 紫苏籽粕的综合利用方法 |
| WO2019201430A1 (en) * | 2018-04-17 | 2019-10-24 | Protea Biopharma N.V. | Sustained energy providing and free radical protective composition |
| KR102040972B1 (ko) * | 2018-09-14 | 2019-11-05 | 마이크로바이오주식회사 | 피부 노화 방지 또는 주름 개선 활성이 있는 신규한 비피도박테리움 락티스(Bifidobacterium lactis) UBC-U04 및 이를 이용한 조성물 |
| CN110172493A (zh) * | 2019-05-28 | 2019-08-27 | 湖南中医药大学 | 一种咖啡酸的制备方法 |
| CN114288333B (zh) * | 2021-12-28 | 2022-10-21 | 中国科学院植物研究所 | 一种抑制皮肤黑素瘤细胞增殖的迷迭香复方精油及其用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0577904B1 (fr) | 1992-07-06 | 1997-05-14 | Societe Des Produits Nestle S.A. | Bactérie lactique |
| US6245363B1 (en) * | 1995-06-07 | 2001-06-12 | Zylepsis Limited | Methods of treating plant materials with hydrolytic enzymes isolated from humicola species |
| FR2755368B1 (fr) * | 1996-11-04 | 1999-03-19 | Oreal | Composition rincable pour le soin de la peau |
| FR2788435B1 (fr) * | 1999-01-15 | 2002-08-02 | Oreal | Utilisation d'un extrait d'un vegetal du genre rosmarinus dans des compositions destinees a traiter les signes cutanes du vieillissement |
| EP1110555A1 (fr) * | 1999-12-22 | 2001-06-27 | Societe Des Produits Nestle S.A. | Agent anti-adhesion de la flore pathogene de la peau |
| EP1151673A3 (en) | 2000-05-03 | 2002-01-02 | Societe Des Produits Nestle S.A. | Confectionery product having a filling |
| WO2002047701A1 (en) * | 2000-12-12 | 2002-06-20 | Angiolab, Inc. | Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| KR20030082764A (ko) * | 2002-04-18 | 2003-10-23 | 에스케이케미칼주식회사 | 관절조직 보호 작용을 갖는 생약조성물 |
| AU2003284985A1 (en) * | 2002-10-23 | 2004-05-13 | Rutgers, The State University Of New Jersey | Production of vanillin in microbial cells |
| FR2848851B1 (fr) * | 2002-12-20 | 2006-03-10 | Procede d'obtention d'un principe actif presentant des capacites apaisantes, principe actif et compositions obtenues | |
| US20050037094A1 (en) * | 2003-07-31 | 2005-02-17 | Xijun Yan | Composition for heart disease, its active ingredients, method to prepare same and uses thereof |
| EP1604647B1 (en) * | 2004-05-12 | 2008-05-07 | Chisso Corporation | Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof |
| US20060269508A1 (en) * | 2005-03-29 | 2006-11-30 | Trejo Amy V | Means for regulating the cosmetic appearance and/or health of human keratinous tissue |
| EP2210504A1 (en) * | 2009-01-27 | 2010-07-28 | Nestec S.A. | Composition comprising chicoric acid and/or derivatives thereof |
-
2006
- 2006-11-06 EP EP06023060A patent/EP1917960A1/en not_active Withdrawn
-
2007
- 2007-11-05 AR ARP070104924A patent/AR063570A1/es active IP Right Grant
- 2007-11-06 CA CA2668472A patent/CA2668472C/en not_active Expired - Fee Related
- 2007-11-06 EP EP07819621A patent/EP2081566B1/en not_active Not-in-force
- 2007-11-06 TW TW096141951A patent/TWI494101B/zh not_active IP Right Cessation
- 2007-11-06 CL CL200703203A patent/CL2007003203A1/es unknown
- 2007-11-06 AU AU2007316954A patent/AU2007316954B2/en not_active Ceased
- 2007-11-06 CN CN200780040651.1A patent/CN101563078B/zh not_active Expired - Fee Related
- 2007-11-06 ES ES07819621T patent/ES2344127T3/es active Active
- 2007-11-06 BR BRPI0718533A patent/BRPI0718533B8/pt not_active IP Right Cessation
- 2007-11-06 WO PCT/EP2007/009602 patent/WO2008055651A1/en not_active Ceased
- 2007-11-06 AT AT07819621T patent/ATE461699T1/de not_active IP Right Cessation
- 2007-11-06 DE DE602007005506T patent/DE602007005506D1/de active Active
- 2007-11-06 US US12/513,631 patent/US8932579B2/en not_active Expired - Fee Related
- 2007-11-06 MX MX2009004739A patent/MX2009004739A/es active IP Right Grant
-
2013
- 2013-09-18 US US14/030,611 patent/US9314490B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE461699T1 (de) | 2010-04-15 |
| US8932579B2 (en) | 2015-01-13 |
| AU2007316954B2 (en) | 2013-04-18 |
| BRPI0718533B1 (pt) | 2020-08-18 |
| WO2008055651A1 (en) | 2008-05-15 |
| AU2007316954A1 (en) | 2008-05-15 |
| BRPI0718533B8 (pt) | 2021-05-25 |
| US20140023625A1 (en) | 2014-01-23 |
| US20100129324A1 (en) | 2010-05-27 |
| CN101563078A (zh) | 2009-10-21 |
| CN101563078B (zh) | 2015-01-21 |
| TW200829233A (en) | 2008-07-16 |
| CA2668472C (en) | 2015-04-07 |
| EP2081566B1 (en) | 2010-03-24 |
| CA2668472A1 (en) | 2008-05-15 |
| EP2081566A1 (en) | 2009-07-29 |
| CL2007003203A1 (es) | 2008-07-04 |
| MX2009004739A (es) | 2009-07-17 |
| DE602007005506D1 (de) | 2010-05-06 |
| ES2344127T3 (es) | 2010-08-18 |
| BRPI0718533A2 (pt) | 2013-11-26 |
| US9314490B2 (en) | 2016-04-19 |
| TWI494101B (zh) | 2015-08-01 |
| EP1917960A1 (en) | 2008-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR063570A1 (es) | Efectos biologicos mejorados para composiciones que comprenden acido rosmarinico | |
| UY29853A1 (es) | Derivados de diacilindazol como inhibidores de lipasas y fosfolipasas- | |
| AR070497A1 (es) | Composicion detergente que comprende lipasa | |
| UY30918A1 (es) | Moduladores de lta4h y sus usos | |
| BRPI1013388A2 (pt) | composição de limpeza que compreende uma alfa-amilase e uma protease e método de limpeza de um tecido ou superficie dura | |
| ES2572160T3 (es) | Una nueva preparación farmacéutica para preeclampsia | |
| CO6470854A2 (es) | Variantes de celulasa con expresión, actividad y/o estabilidad mejoradas, y uso de las mismas | |
| ECSP11010746A (es) | Salicilatos acetilados con ácidos grasos y sus usos | |
| ECSP10010735A (es) | Compuestos químicos 251 | |
| DOP2012000261A (es) | Formulaciones de insulina de accion prolongada | |
| NI200700250A (es) | Moduladores de fenilo y piridilo de lta4h | |
| MX352328B (es) | Formulaciones orales de ester de testosterona y metodos para el tratamiento de la deficiencia de testosterona que comprende estos. | |
| CL2007001391A1 (es) | Compuestos derivados de pirrolidinas sustituidas, inhibidores del factor xa y/o inhibidores sobre la serina proteasa; composicion farmaceutica que comprende a dichos compuestos; proedimiento para preparar la composicon farmaceutica; y uso de los compuestos preparar un medicamneto con un efecto antitrombotico | |
| CO6640205A2 (es) | Microorganismos y metodos para la biosintesis de p-toluato y tereftalato | |
| ECSP088377A (es) | Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas | |
| GT201000037A (es) | Depsipéptidos cíclicos | |
| TW200800987A (en) | Triazolopyridine derivatives as inhibitors of lipases and phospholipases | |
| ECSP088884A (es) | Compuestos heterociclicos fusionados y su uso como moduladores de mglur5 | |
| UY31001A1 (es) | Derivados de imidazolidinacarboxamida como inhibidores de lipasas y fosfolipasas | |
| BRPI0922653B8 (pt) | uso de uma lipase bacteriana do tipo pseudomonas em solução aquosa | |
| CL2012000658A1 (es) | Composicion farmaceutica que comprende microesferas entericamente recubiertas que contienen enzimas digestivas tal como lipasa y microesferas no recubiertas entericamente que contienen enzimas digestivas tal como proteasa; forma de dosis; y su uso tratar el dolor de pancreatitis e insuficiencia pancreatica. | |
| CY1110213T1 (el) | Παραγωγα αζολοπυριδιν-2-ονης ως αναστολεις λιπασων και φωσφολιπασων | |
| BRPI0618654A8 (pt) | variante de zimogênio/protease de fator x/fator xa, ácido nucléico, composição farmacêutica que os contém, vetor, bem como uso dos mesmos | |
| CL2012001712A1 (es) | Compuestos derivados de heterociclos nitrogenados, moduladores de crth2; composición farmacéutica; y su uso para preparar un medicamento útil en el tratamiento de asma, dermatitis alérgica, rinitis alérgica, bronquitis crónica, fibrosis pulmonar idiopática, entre otras. | |
| CL2011000621A1 (es) | Agente que contiene por lo menos un acido acilciclohexanodionacarboxilico y/o sus sales en combinacion con por lo menos un ester de acido acilciclohexanodionacarboxilico y su uso para mejorar el desarrollo de gramineas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |